Apolipoprotein A4 (APOA4) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Apolipoprotein A4 (APOA4) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityApolipoprotein A4 (APOA4)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpurified
Size80 µl, 400 µl,
Concentrationn/a
ApplicationsELISA, WB, IHC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe primary translation product of the APOA4 gene is a 396-residue preprotein which after proteolytic processing is secreted into its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A4 is a potent activator of lecithin-cholesterol acyltransferase in vitro.
ImmunogenKLH-conjugated synthetic peptide between 49-79 amino acids from the N-terminal region of human APOA4.
Other NamesAPOA4, Apolipoprotein A-IV, Apolipoprotein A4, MGC142154, MGC142156, ApoA-IV, APOA4, APOA4, APOA4 , APOA4 , Apolipoprotein A-IV, Apolipoprotein A-IV, Apolipoprotein A-IV , Apolipoprotein A-IV , Apolipoprotein A4, Apolipoprotein A4, Apolipoprotein A4 , Apolipoprotein A4 , MGC142154, MGC142154, MGC142154 , MGC142154 , MGC142156, MGC142156, MGC142156 , MGC142156 , ApoA-IV, ApoA-IV, ApoA-IV , ApoA-IV
Gene, Accession #UniProt: P06727
Catalog #abx025128
Priceplease inquire
Order / More InfoApolipoprotein A4 (APOA4) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.